Lataa...
Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain-barrier and impairs iron-dependent hippocampal neuron dendrite development
BACKGROUND: Thrombocytopenia is common in sick neonates. Thrombopoietin mimetics (e.g., eltrombopag (ELT)) might provide an alternative therapy for selected neonates with severe and prolonged thrombocytopenia, and for infants and young children with different varieties of thrombocytopenia. However,...
Tallennettuna:
| Julkaisussa: | J Thromb Haemost |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334144/ https://ncbi.nlm.nih.gov/pubmed/28005311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13602 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|